Alternative treatment for T4 breast cancer involving preoperative radiotherapy and immediate reconstruction
Official title: Feasibility of Preoperative Radiotherapy in T3 and T4 Breast Cancer Patients Who Are Responders to Neoadjuvant Chemotherapy to Allow for Immediate Reconstruction: a Prospective Study
Run by Memorial Sloan Kettering Cancer Center · NCT05412225 · Data updated 2026-11-12
This study is testing a new treatment for T4 breast cancer that combines radiation before surgery with immediate reconstruction to see if it can improve patient outcomes.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 7 sites (Basking Ridge, New Jersey and 6 other locations) |
| Status | Recruiting |
| Started | June 6, 2022 |
| Main results expected | June 6, 2027 |
| Study ends | June 6, 2027 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT05412225 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 18 and older with biopsy-proven invasive breast cancer and specific tumor characteristics.
✕Probably not a fit
Patients with prior breast cancer, stage IV disease, or those who are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a new treatment approach for T4 breast cancer that includes preoperative radiotherapy followed by mastectomy and immediate autologous reconstruction surgery. The goal is to evaluate the feasibility and safety of this alternative method compared to standard treatment practices. Participants will undergo neoadjuvant radiotherapy before their surgery, and the reconstruction will use tissue from another part of their body immediately after the mastectomy. The study aims to determine if this approach can improve outcomes for patients with invasive breast cancer.
Why it matters
Potential benefit: If successful, this treatment could provide a more effective and immediate reconstruction option for patients with T4 breast cancer.
How similar studies have gone: Other studies have explored similar approaches, but this specific combination of preoperative radiotherapy and immediate reconstruction is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex, aged ≥18 years, with biopsy-proven invasive breast cancer * cT3-4 cN0-3 tumor * Partial or complete response to NAC on imaging and clinical examination using the Response Evaluation Criteria in Solid Tumors (RECISTv1.1) definition. * Desire to undergo autologous reconstruction and assessed to be an appropriate candidate by a plastic and reconstructive surgeon * Able to read and understand English Exclusion Criteria: * Prior ipsilateral breast cancer * Bilateral breast cancer * Pregnant * Stage IV disease at presentation * Stable disease or progressive disease after NAC * Surgically unresectable breast disease * BMI \>40 * Prior history of thoracic radiotherapy
Where it's running
-
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States Recruiting -
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States Recruiting -
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States Recruiting -
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Commack, New York, United States Recruiting -
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, United States Recruiting -
Memorial Sloan Kettering Cancer Center
New York, New York, United States Recruiting
Show 1 more location
-
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, United States Recruiting
Study contacts
- Principal investigator: Minna Lee, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Minna Lee, MD
- Email: leem15@mskcc.org
- Phone: 646-888-6898
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
68Ga-FAPI PET/MRI imaging to see if it can track breast cancer response to chemotherapy
This study tests whether a new imaging scan, 68Ga-FAPI PET/MRI, can show how well invasive breast cancer responds to neoadjuvant chemotherapy in adults.
-
Preoperative partial breast irradiation for early-stage breast cancer
This study is testing if giving radiation therapy before surgery for early-stage breast cancer can lead to fewer side effects compared to the usual treatment given after surgery.
-
Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients
This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.
-
Testing a new drug combination for HER2-positive inflammatory breast cancer
This study is testing a new combination of two drugs to see if they can safely and effectively treat people with stage III HER2-positive inflammatory breast cancer who haven't had treatment before.
-
Collection of breast cancer tissue and blood samples
This study is collecting breast cancer tissue and blood samples from patients during surgery to help with future research on the disease.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.